Literature DB >> 17593489

Negative autoregulation of RANKL and c-Src signaling in osteoclasts.

Keiichiro Yogo1, Norihiro Ishida-Kitagawa, Tatsuo Takeya.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593489     DOI: 10.1007/s00774-007-0751-2

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.976


× No keyword cloud information.
  62 in total

1.  Induction of mouse c-src in RAW264 cells is dependent on AP-1 and NF-kappaB and important for progression to multinucleated cell formation.

Authors:  Naoko Kumagai; Keita Ohno; Ryusuke Tameshige; Mitsuhiro Hoshijima; Keiichiro Yogo; Norihiro Ishida; Tatsuo Takeya
Journal:  Biochem Biophys Res Commun       Date:  2004-12-17       Impact factor: 3.575

Review 2.  Osteoclast signalling pathways.

Authors:  Harry C Blair; Lisa J Robinson; Mone Zaidi
Journal:  Biochem Biophys Res Commun       Date:  2005-03-18       Impact factor: 3.575

3.  Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.

Authors:  E Tsuda; M Goto; S Mochizuki; K Yano; F Kobayashi; T Morinaga; K Higashio
Journal:  Biochem Biophys Res Commun       Date:  1997-05-08       Impact factor: 3.575

4.  Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density.

Authors:  S Umeda; W G Beamer; K Takagi; M Naito; S Hayashi; H Yonemitsu; T Yi; L D Shultz
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

5.  osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

Authors:  N Bucay; I Sarosi; C R Dunstan; S Morony; J Tarpley; C Capparelli; S Scully; H L Tan; W Xu; D L Lacey; W J Boyle; W S Simonet
Journal:  Genes Dev       Date:  1998-05-01       Impact factor: 11.361

6.  Src homology 2 (SH2)-containing 5'-inositol phosphatase localizes to podosomes, and the SH2 domain is implicated in the attenuation of bone resorption in osteoclasts.

Authors:  Keiichiro Yogo; Megumi Mizutamari; Kazuta Mishima; Hiromi Takenouchi; Norihiro Ishida-Kitagawa; Takehiko Sasaki; Tatsuo Takeya
Journal:  Endocrinology       Date:  2006-04-06       Impact factor: 4.736

Review 7.  The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function.

Authors:  William C Horne; Archana Sanjay; Angela Bruzzaniti; Roland Baron
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

8.  SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts.

Authors:  Sunao Takeshita; Noriyuki Namba; Jenny J Zhao; Yebin Jiang; Harry K Genant; Matthew J Silva; Michael D Brodt; Cheryl D Helgason; Janet Kalesnikoff; Michael J Rauh; R Keith Humphries; Gerald Krystal; Steven L Teitelbaum; F Patrick Ross
Journal:  Nat Med       Date:  2002-08-05       Impact factor: 53.440

9.  TSH is a negative regulator of skeletal remodeling.

Authors:  Etsuko Abe; Russell C Marians; Wanqin Yu; Xue Bin Wu; Takao Ando; Yanan Li; Jameel Iqbal; Leslie Eldeiry; Gopalan Rajendren; Harry C Blair; Terry F Davies; Mone Zaidi
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

Review 10.  The expanding role of PI3-kinase in bone.

Authors:  Lauren H Golden; Karl L Insogna
Journal:  Bone       Date:  2004-01       Impact factor: 4.398

View more
  2 in total

1.  A Follow-up Association Study of Genetic Variants for Bone Mineral Density in a Korean Population.

Authors:  Seokjin Ham; Tae-Young Roh
Journal:  Genomics Inform       Date:  2014-09-30

Review 2.  Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases.

Authors:  Zhiguo Ling; Chuan Yang; Jiulin Tan; Ce Dou; Yueqi Chen
Journal:  Cell Mol Life Sci       Date:  2021-10-11       Impact factor: 9.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.